402 related articles for article (PubMed ID: 18779049)
1. Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development.
Pierson TC; Fremont DH; Kuhn RJ; Diamond MS
Cell Host Microbe; 2008 Sep; 4(3):229-38. PubMed ID: 18779049
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection.
Pierson TC; Diamond MS
Expert Rev Mol Med; 2008 May; 10():e12. PubMed ID: 18471342
[TBL] [Abstract][Full Text] [Related]
3. The role of anti-flavivirus humoral immune response in protection and pathogenesis.
Hurtado-Monzón AM; Cordero-Rivera CD; Farfan-Morales CN; Osuna-Ramos JF; De Jesús-González LA; Reyes-Ruiz JM; Del Ángel RM
Rev Med Virol; 2020 Jul; 30(4):e2100. PubMed ID: 32101633
[TBL] [Abstract][Full Text] [Related]
4. The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design.
Rey FA; Stiasny K; Vaney MC; Dellarole M; Heinz FX
EMBO Rep; 2018 Feb; 19(2):206-224. PubMed ID: 29282215
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of antibody-mediated neutralization and protection against flavivirus.
Dai L; Wang Q; Qi J; Shi Y; Yan J; Gao GF
IUBMB Life; 2016 Oct; 68(10):783-91. PubMed ID: 27604155
[TBL] [Abstract][Full Text] [Related]
6. Membrane and envelope virus proteins co-expressed as lysosome associated membrane protein (LAMP) fused antigens: a potential tool to develop DNA vaccines against flaviviruses.
Dhalia R; Maciel M; Cruz FS; Viana IF; Palma ML; August T; Marques ET
An Acad Bras Cienc; 2009 Dec; 81(4):663-9. PubMed ID: 19893892
[TBL] [Abstract][Full Text] [Related]
7. Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity.
VanBlargan LA; Goo L; Pierson TC
Microbiol Mol Biol Rev; 2016 Dec; 80(4):989-1010. PubMed ID: 27784796
[TBL] [Abstract][Full Text] [Related]
8. A game of numbers: the stoichiometry of antibody-mediated neutralization of flavivirus infection.
Pierson TC; Diamond MS
Prog Mol Biol Transl Sci; 2015; 129():141-66. PubMed ID: 25595803
[TBL] [Abstract][Full Text] [Related]
9. Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization.
Chávez JH; Silva JR; Amarilla AA; Moraes Figueiredo LT
Biologicals; 2010 Nov; 38(6):613-8. PubMed ID: 20817489
[TBL] [Abstract][Full Text] [Related]
10. The Many Faces of a Dynamic Virion: Implications of Viral Breathing on Flavivirus Biology and Immunogenicity.
Dowd KA; Pierson TC
Annu Rev Virol; 2018 Sep; 5(1):185-207. PubMed ID: 30265634
[TBL] [Abstract][Full Text] [Related]
11. Mapping the diverse structural landscape of the flavivirus antibody repertoire.
Sevvana M; Kuhn RJ
Curr Opin Virol; 2020 Dec; 45():51-64. PubMed ID: 32801077
[TBL] [Abstract][Full Text] [Related]
12. Immunization with Immune Complexes Modulates the Fine Specificity of Antibody Responses to a Flavivirus Antigen.
Tsouchnikas G; Zlatkovic J; Jarmer J; Strauß J; Vratskikh O; Kundi M; Stiasny K; Heinz FX
J Virol; 2015 Aug; 89(15):7970-8. PubMed ID: 26018152
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex.
Lobigs M; Diamond MS
Expert Rev Vaccines; 2012 Feb; 11(2):177-87. PubMed ID: 22309667
[TBL] [Abstract][Full Text] [Related]
14. Mechanism and significance of cell type-dependent neutralization of flaviviruses.
Mukherjee S; Dowd KA; Manhart CJ; Ledgerwood JE; Durbin AP; Whitehead SS; Pierson TC
J Virol; 2014 Jul; 88(13):7210-20. PubMed ID: 24741083
[TBL] [Abstract][Full Text] [Related]
15. Entry functions and antigenic structure of flavivirus envelope proteins.
Stiasny K; Kiermayr S; Heinz FX
Novartis Found Symp; 2006; 277():57-65; discussion 65-73, 251-3. PubMed ID: 17319154
[TBL] [Abstract][Full Text] [Related]
16. Protective immune response against newly emerging goose tembusu virus infection induced by immunization with a recombinant envelope protein.
Zhao D; Huang X; Han K; Liu Y; Yang J; Liu Q; An F; Li Y
Lett Appl Microbiol; 2015 Oct; 61(4):318-24. PubMed ID: 26108865
[TBL] [Abstract][Full Text] [Related]
17. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764
[TBL] [Abstract][Full Text] [Related]
18. CD4 T cell responses to flaviviruses.
Aberle JH; Koblischke M; Stiasny K
J Clin Virol; 2018 Nov; 108():126-131. PubMed ID: 30312909
[TBL] [Abstract][Full Text] [Related]
19. Antibody-mediated neutralization of flaviviruses: a reductionist view.
Dowd KA; Pierson TC
Virology; 2011 Mar; 411(2):306-15. PubMed ID: 21255816
[TBL] [Abstract][Full Text] [Related]
20. Impact of flavivirus vaccine-induced immunity on primary Zika virus antibody response in humans.
Malafa S; Medits I; Aberle JH; Aberle SW; Haslwanter D; Tsouchnikas G; Wölfel S; Huber KL; Percivalle E; Cherpillod P; Thaler M; Roßbacher L; Kundi M; Heinz FX; Stiasny K
PLoS Negl Trop Dis; 2020 Feb; 14(2):e0008034. PubMed ID: 32017766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
